Literature DB >> 11857354

Candidate tumor suppressor, HCCS-1, is downregulated in human cancers and induces apoptosis in cervical cancer.

Tae E Kim1, Yong W Kim, Seung Y Hwang, Seung M Shin, Jin W Shin, Young H Lee, Sun Y Shin, Ku T Han, Joon M Lee, Sung E Namkoong, Jin W Kim.   

Abstract

To identify the genes involved in cervical carcinogenesis, we applied the mRNA differential display method and identified a candidate tumor suppressor gene, HCCS-1, which was present in normal cervical tissue but absent in cervical cancer, metastatic lymph node and CUMC-6 cervical cancer cell line. HCCS-1 transcripts were expressed in many normal tissues including leukocyte, lung, spleen, liver, heart and uterine cervix. Its expression was absent in 8 human cancer cell lines. HCCS-1-transfected HeLa cells exhibited growth inhibition by about 50%. This inhibitory effect of HCCS-1 on cervical cancer cells was associated with apoptotic process including DNA fragmentation. HCCS-1-transfected HeLa cells were shown to release cytochrome c from mitochondria, which activates caspase-9 and -3 and finally results in cleavage of poly(ADP-ribose) polymerase. Apoptosis formation was detected by propidium-iodide/annexin V. HCCS-1-transfected HeLa cells were more sensitive to adriamycin or UVC ray triggered apoptosis. These results suggest that HCCS-1 is downregulated in multiple human tumor types and may serve as a candidate tumor suppressor gene through apoptotic pathway against human cervical cancer. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857354     DOI: 10.1002/ijc.10124

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  VPS53 Suppresses Malignant Properties in Colorectal Cancer by Inducing the Autophagy Signaling Pathway.

Authors:  Hong Peng; Jie Zheng; Qiang Su; Xueya Feng; Mingsha Peng; Lei Gong; Hong Wu; Xue Pan
Journal:  Onco Targets Ther       Date:  2020-10-21       Impact factor: 4.147

2.  Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression.

Authors:  Guoqing Wang; Lei Lei; Xixia Zhao; Jun Zhang; Min Zhou; Kejun Nan
Journal:  Oncol Res       Date:  2014       Impact factor: 5.574

3.  Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis.

Authors:  Tania Rossi; Davide Angeli; Michela Tebaldi; Pietro Fici; Elisabetta Rossi; Andrea Rocca; Michela Palleschi; Roberta Maltoni; Giovanni Martinelli; Francesco Fabbri; Giulia Gallerani
Journal:  Cancers (Basel)       Date:  2022-08-14       Impact factor: 6.575

4.  Expression and clinical significance of HCCS1 in non-small cell lung cancer.

Authors:  Shen Xiao-Yong; Lin Zhi-Feng; Lu Fan-Zhen; Ruan Zhen; Zhen Jian; Huang Hai-Long; Ju Chao-Qiang
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29

5.  A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin.

Authors:  Sean M Santos; John L Hartman
Journal:  Cancer Metab       Date:  2019-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.